Clinical trials: Auricular Reconstruction
- Condition Auricular Reconstruction
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Microtia
AuriNovo for Auricular Reconstruction
AuriNovo provides a patient-specific, biological construct for use in the surgical reconstruction of the external ear in people born with microtia Grades II-IV.
- Trial name
- NCT04399239
- Testing
- AuriNovo
- Where
- 2 sites in United States
- Volunteers
- 2 people
- Sponsor
- 3DBio Therapeutics